STRS Ohio’s Cabaletta Bio CABA Stock Holding History

STRS Ohio’s Portfolio CABA Stock Details CABA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-1,700	Closed	-$18K	–	2202
2020 Q2	$18K	Hold	1,700	–	–	﹤0.01%	2049
2020 Q1	$12K	Hold	1,700	–	–	﹤0.01%	1930
2019 Q4	$23K	Buy	+1,700	New	+$20.1K	﹤0.01%	1961

Other funds holding CABA

5VM

5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

STRS Ohio's CABA Position: Q3 2020 in Review

STRS Ohio sold out of Cabaletta Bio (CABA) in Q3 2020, closing a stake of 1,700 shares — an estimated $18K sold.

STRS Ohio first reported a position in CABA in Q4 2019 and held it in 3 quarters. The position peaked at $23K in Q4 2019. 54 funds tracked by Wall St. Rank hold CABA as of Q3 2020.

STRS Ohio reported no remaining Cabaletta Bio position as of Q3 2020 after selling out during the quarter.
STRS Ohio sold 1,700 Cabaletta Bio shares in Q3 2020, an estimated $18K.
STRS Ohio first reported a position in Cabaletta Bio in Q4 2019 and held it in 3 quarters.
STRS Ohio's Cabaletta Bio position peaked at $23K in Q4 2019.
54 funds tracked by Wall St. Rank held Cabaletta Bio as of Q3 2020.

Based on STRS Ohio's 13F filing for Q3 2020, filed 14 Dec 2020.